Further combining overall and disease-free survival analysis using the GEPIA website, we identified that TOP2A, ASPM, and CCNB2 were promising prognostic markers and potential therapeutic targets for HCC. This evidence concerns the gene CCNB2 and hepatocellular carcinoma.